EVOFEM BIOSCIENCES, INC. Gain (Loss) on Sale of Derivatives
EVOFEM BIOSCIENCES, INC. (EVFM) reported Gain (Loss) on Sale of Derivatives of -$3.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2026-03-11
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for the quarter ending 2024-12-31 was $0.00.
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for the quarter ending 2024-09-30 was $0.00.
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for the quarter ending 2024-06-30 was -$25.00K.
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for the quarter ending 2024-03-31 was -$3.27M.
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for fiscal 2024 was -$3.30M.
- EVOFEM BIOSCIENCES, INC. gain (loss) on sale of derivatives for fiscal 2023 was -$6.78M.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | -$25.00K derived: sum of 3 quarters · filed 2026-03-11 | -$3.30M 10-K · filed 2026-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$25.00K derived: sum of 2 quarters · filed 2025-11-13 | -$3.30M 10-Q · filed 2025-11-13 | -$4.79M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$25.00K 10-Q · filed 2025-08-14 | -$3.30M 10-Q · filed 2025-08-14 | -$4.79M derived: sum of 3 quarters · filed 2025-08-14 | -$9.96M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$3.27M 10-Q · filed 2025-05-15 | -$4.76M derived: sum of 2 quarters · filed 2025-05-15 | -$9.94M derived: sum of 3 quarters · filed 2025-05-15 | -$9.97M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$6.67M derived: sum of 2 quarters · filed 2025-03-24 | -$6.69M derived: sum of 3 quarters · filed 2025-03-24 | -$6.78M 10-K · filed 2025-03-24 |
| 2023-09-30 | -$5.17M 10-Q · filed 2024-11-14 | -$5.20M derived: sum of 2 quarters · filed 2024-11-14 | -$5.29M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$27.00K 10-Q · filed 2024-08-14 | -$111.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$84.00K 10-Q · filed 2024-05-15 |